Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

Exclusion Criteria

• •Patient has a legal incapacity or limited legal capacity without legal guardian representation
• •Patient is currently participating in an interventional study of any investigational product, device or procedure
• •Patient has a hypersensitivity to the active substance or to any of the excipients listed in Section 6.1 of the Summary of Product Characteristics
• •Patient has a generalised disorder of muscle activity (e.g. myasthenia gravis or Eaton Lambert Syndrome)
• •Patient has an infection or inflammation at any of the proposed injection sites
• •Patient has a history of dysphagia and/or aspiration
• •Female patient is pregnant, is of childbearing potential and not using contraception, is breast feeding, or is planning to become pregnant during the next 18 months
• •Patient has received prior botulinum toxin for any indication within 3 months of study enrolment.